Table 3.
Odds ratio for lymphoma according to current measured 25(OH)D, Rochester, New York, 2005–2007.
| Vitamin D |
Controls n=132 | All Lymphoma Cases |
Only NHL Cases |
||
|---|---|---|---|---|---|
| 25(OH)D range (ng/ml) | Cases n=132 | Adjusteda odds ratio (95% confidence interval) | Cases n=121 | Adjusteda odds ratio (95% confidence interval) | |
| Insufficient (<30) | 97 | 98 | 0.89 (0.47–1.72) | 88 | 0.86 (0.44–1.68) |
| Sufficient (≥30) | 35 | 34 | 1.0 (reference) | 34 | 1.0 (reference) |
| Tertileb 1 (<20.9) | 42 | 55 | 1.32 (0.66–2.66) | 50 | 1.38 (0.67–2.85) |
| Tertile 2 (20.9–28.5) | 45 | 37 | 0.79 (0.39–1.63) | 33 | 0.79 (0.38–1.68) |
| Tertile 3 (≥28.6) | 45 | 40 | 1.0 (reference) | 38 | 1.0 (reference) |
| ptrendc | 0.39 | 0.35 | |||
| Continuous | 132 | 132 | 0.99 (0.96–1.03) | 121 | 0.99 (0.96–1.03) |
NHL, non-Hodgkin lymphoma;
a
ORs adjusted for age (continuous), gender, race (white, black, other), prior skin cancer diagnosis (BCC, SCC, melanoma), known family history of lymphoma, known family history of other cancer, BMI (continuous), and season (Winter: December–February; Spring/Fall: March–May, September–November; Summer: June–August);
b
Tertiles set according to distribution of serum 25(OH)D levels among the controls;
c
ptrend is based on ordinal score.